Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Libman-Sacks Endocarditis Presenting as Severe Mitral Stenosis.

CASE (Philadelphia, Pa.)·2026
Same author

Sex Differences in Spontaneous Coronary Artery Dissection: A Report of the iSCAD Registry.

Journal of the American Heart Association·2026
Same author

Cardiovascular Burden of the V142I Transthyretin Variant.

JAMA·2024
Same author

The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.

JAMA·2024
Same author

Heart Failure Risk Among African-American Women With an ICAM1 Missense Variant.

JACC. Heart failure·2024
Same author

Contributions of the Women's Health Initiative to Cardiovascular Research: JACC State-of-the-Art Review.

Journal of the American College of Cardiology·2022

Related Experiment Video

Updated: Jun 2, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

Peripartum cardiomyopathy: a current review.

Katie M Twomley1, Gretchen L Wells

  • 1Section on Cardiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1045, USA.

Journal of Pregnancy
|April 15, 2011
PubMed
Summary

Peripartum cardiomyopathy (PPCM) is a rare heart condition affecting pregnant women. This review covers PPCM causes, diagnosis, and current treatment options for better patient outcomes.

Area of Science:

  • Cardiology
  • Obstetrics
  • Maternal Health

Background:

  • Peripartum cardiomyopathy (PPCM) is a rare, potentially fatal heart condition affecting women late in pregnancy or postpartum.
  • Incidence is approximately 1:3,000 live births in the US, with higher risks noted in African-American women.
  • Diagnosis involves heart failure symptoms, absence of prior cardiac disease, and confirmed left ventricular systolic dysfunction.

Purpose of the Study:

  • To provide a comprehensive and updated review of Peripartum Cardiomyopathy (PPCM).
  • To explore emerging insights into the etiology (causes) of PPCM.
  • To summarize current treatment strategies for PPCM.

Main Methods:

  • Literature review of Peripartum Cardiomyopathy (PPCM).
  • Synthesis of diagnostic criteria for PPCM.

Related Experiment Videos

Last Updated: Jun 2, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

  • Analysis of current and emerging treatment options for PPCM.

    • Main Results:

    • PPCM presents with heart failure symptoms in late pregnancy or postpartum.
    • Left ventricular systolic dysfunction is a key diagnostic marker.
    • Etiology is multifactorial, with ongoing research into specific triggers.

    Conclusions:

    • PPCM requires prompt diagnosis and management.
    • Understanding PPCM etiology is crucial for developing targeted therapies.
    • Current treatments focus on managing heart failure symptoms and improving cardiac function.